Observational studyRetina (Philadelphia, Pa.)2019

MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen.

Irmela Mantel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.